The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial

International Orthopaedics

Volumn 41, Issue 10, 2017, Pages 2053-2059

  Lei, Yiting ^a   Xie, Jinwei ^a   Xu, Bin ^a   Xie, Xiaowei ^a   Huang, Qiang ^a   Pei, Fuxing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Blood loss; Multiple dose treatment; Randomized controlled trial; Total knee arthroplasty; Tranexamic acid

Indexed keywords

D DIMER; FIBRIN DEGRADATION PRODUCT; HEMOGLOBIN; INTERLEUKIN 6; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; BIOLOGICAL MARKER; FIBRIN FRAGMENT D;

ADULT; ARTICLE; BLOOD TRANSFUSION; BOLUS INJECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYSIS; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; INFLAMMATION; INTRAMUSCULAR VENOUS THROMBOSIS; KNEE OSTEOARTHRITIS; LAMINAR FLOW; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE DRUG DOSE; OPERATIVE BLOOD LOSS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; RHEUMATOID ARTHRITIS; SKIN INCISION; SURGICAL PATIENT; TOTAL KNEE ARTHROPLASTY; TREATMENT OUTCOME; VEIN THROMBOSIS; AGED; BLOOD; INTRAVENOUS DRUG ADMINISTRATION; JOINT CHARACTERISTICS AND FUNCTIONS; KNEE REPLACEMENT; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADMINISTRATION, INTRAVENOUS; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BIOMARKERS; BLOOD TRANSFUSION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOGLOBINS; HUMANS; INTERLEUKIN-6; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 85020121239     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-017-3519-x     Document Type: Article

References (26)

1. Xie J, Ma J, Yao H, Yue C, Pei F (2016) Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. J Arthroplast. doi:10.1016/j.arth.2016.04.034
2. Hogan CA, Golightly LK, Phong S, Dayton MR, Lyda C, Barber GR (2016) Perioperative blood loss in total hip and knee arthroplasty: outcomes associated with intravenous tranexamic acid use in an academic medical center. SAGE Open Med 4:2050312116637024. doi:10.1177/2050312116637024
3. Holt JB, Miller BJ, Callaghan JJ, Clark CR, Willenborg MD, Noiseux NO (2016) Minimizing blood transfusion in total hip and knee arthroplasty through a multimodal approach. J Arthroplast 31(2):378–382. doi:10.1016/j.arth.2015.08.025
4. Rineau E, Chaudet A, Chassier C, Bizot P, Lasocki S (2016) Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study. Transfusion 56(3):673–681. doi:10.1111/trf.13468
5. Liu KL, Chen IH, Wen SH (2016) Low dose tranexamic acid reduces blood transfusion rate after total knee arthroplasty: a population-based study in Taiwan. J Formos Med Assoc. doi:10.1016/j.jfma.2015.12.012
6. Oremus K (2015) Tranexamic acid for the reduction of blood loss in total knee arthroplasty. Ann Transl Med 3(Suppl 1):S40. doi:10.3978/j.issn.2305-5839.2015.03.35
7. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR (2012) Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 470(9):2605–2612. doi:10.1007/s11999-012-2310-y
8. Akgul T, Buget M, Salduz A, Edipoglu IS, Ekinci M, Kucukay S, Sen C (2016) Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: a prospective clinical study. Acta Orthop Traumatol Turc. doi:10.1016/j.aott.2016.06.007
9. Hourlier H, Reina N, Fennema P (2015) Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trial. Arch Orthop Trauma Surg 135(4):465–471. doi:10.1007/s00402-015-2168-z
10. Blanie A, Bellamy L, Rhayem Y, Flaujac C, Samama CM, Fontenay M, Rosencher N (2013) Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study. Thromb Res 131(1):e6–e11. doi:10.1016/j.thromres.2012.11.006
11. Huang Z, Ma J, Shen B, Pei F (2014) Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplast 29(12):2342–2346. doi:10.1016/j.arth.2014.05.026
12. Yue C, Kang P, Yang P, Xie J, Pei F (2014) Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplast 29(12):2452–2456. doi:10.1016/j.arth.2014.03.032
13. Serrano Mateo L, Goudarz Mehdikhani K, Caceres L, Lee YY, Gonzalez Della Valle A (2016) Topical tranexamic acid may improve early functional outcomes of primary total knee arthroplasty. J Arthroplast 31(7):1449–1452. doi:10.1016/j.arth.2016.01.009
14. Li B, Wen Y, Wu H, Qian Q, Lin X, Zhao H (2009) The effect of tourniquet use on hidden blood loss in total knee arthroplasty. Int Orthop 33(5):1263–1268. doi:10.1007/s00264-008-0647-3
15. Wang S, Gao X, An Y (2017) Topical versus intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials. Int Orthop 41(4):739–748. doi:10.1007/s00264-016-3296-y
16. Whiting DR, Duncan CM, Sierra RJ, Smith HM (2015) Tranexamic acid benefits total joint arthroplasty patients regardless of preoperative hemoglobin value. J Arthroplast 30(12):2098–2101. doi:10.1016/j.arth.2015.05.050
17. Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV (2013) Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee 20(5):300–309. doi:10.1016/j.knee.2013.05.014
18. Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M (2013) Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop 37(3):441–445. doi:10.1007/s00264-013-1787-7
19. Morais S, Ortega-Andreu M, Rodriguez-Merchan EC, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Zalve R, Gomez-Barrena E (2014) Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach. Int Orthop 38(2):347–354. doi:10.1007/s00264-013-2188-7
20. Jimenez JJ, Iribarren JL, Brouard M, Hernandez D, Palmero S, Jimenez A, Lorente L, Machado P, Borreguero JM, Raya JM, Martin B, Perez R, Martinez R, Mora ML (2011) Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg 6:138. doi:10.1186/1749-8090-6-138
21. Robson SC, Shephard EG, Kirsch RE (1994) Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86(2):322–326
22. Bergin PF, Doppelt JD, Kephart CJ, Benke MT, Graeter JH, Holmes AS, Haleem-Smith H, Tuan RS, Unger AS (2011) Comparison of minimally invasive direct anterior versus posterior total hip arthroplasty based on inflammation and muscle damage markers. J Bone Joint Surg Am 93(15):1392–1398. doi:10.2106/jbjs.j.00557
23. Gilbody J, Dhotar HS, Perruccio AV, Davey JR (2014) Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplast 29(4):681–684. doi:10.1016/j.arth.2013.09.005
24. Xie J, Ma J, Kang P, Zhou Z, Shen B, Yang J, Pei F (2015) Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases. Thromb Res 136(2):234–238. doi:10.1016/j.thromres.2015.05.014
25. Fillingham YA, Kayupov E, Plummer DR, Moric M, Gerlinger TL, Della Valle CJ (2016) The James A. Rand young investigator’s award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost? J Arthroplast 31(9 Suppl):26–30. doi:10.1016/j.arth.2016.02.081
26. Wasko MK, Bobecka-Wesolowska K, Tomasiuk R, Kowalczewski J (2015) Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin Chem Lab Med 53(11):1785–1792. doi:10.1515/cclm-2014-1055